XML 65 R59.htm IDEA: XBRL DOCUMENT v3.24.4
Commitments and Contingencies (Additional Information) (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 28, 2013
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Apr. 30, 2023
Commitments and Contingencies [Line Items]              
Finance lease liabilities   $ 0   $ 0      
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]   Derivative Liability, Noncurrent   Derivative Liability, Noncurrent      
Lease Expense   $ 300 $ 300 $ 800 $ 800    
Additional ROU assets   2,396   2,396   $ 2,943 $ 2,500
Corresponding lease liabilities   1,714   1,714   2,237 $ 2,500
Former Employee [Member]              
Commitments and Contingencies [Line Items]              
Agreement settlement payment       3,500      
Former Employee One[Member]              
Commitments and Contingencies [Line Items]              
Agreement settlement payment       2,500      
GLOPERBA [Member]              
Commitments and Contingencies [Line Items]              
Due From Related Party   500   $ 500      
Epoladerm [Member]              
Commitments and Contingencies [Line Items]              
Percentage on net sale       6.00%      
Probudur [Member]              
Commitments and Contingencies [Line Items]              
Percentage on net sale       6.00%      
Envelta [Member]              
Commitments and Contingencies [Line Items]              
Percentage on net sale       6.00%      
Product Development Agreement [Member] | Developers [Member]              
Commitments and Contingencies [Line Items]              
Royalty expenses   2,200 1,800 $ 6,900 6,100    
Accrued royalty payables   2,200   2,200   $ 2,400  
Agreement maturity date Oct. 02, 2028            
Agreement maturity renewal description The Product Development Agreement will renew automatically for subsequent successive one-year renewal periods unless Scilex Pharma or the Developers terminate it upon 6-month written notice.            
Product Development Agreement [Member] | Developers [Member] | Minimum [Member]              
Commitments and Contingencies [Line Items]              
Royalty payment percentage related to future years 25.00%            
Product Development Agreement [Member] | Developers [Member] | Maximum [Member]              
Commitments and Contingencies [Line Items]              
Royalty payment percentage related to future years 35.00%            
Product Development Agreement [Member] | Scilex Pharma [Member]              
Commitments and Contingencies [Line Items]              
Royalty expenses   $ 2,800 $ 1,100 $ 7,200 $ 5,300    
Non-cancelable Lease Agreements [Member] | Minimum [Member] | Research and Development Facilities [Member]              
Commitments and Contingencies [Line Items]              
Operating lease, remaining lease term   3 years   3 years      
Operating lease, lease term   3 years   3 years      
Non-cancelable Lease Agreements [Member] | Maximum [Member] | Research and Development Facilities [Member]              
Commitments and Contingencies [Line Items]              
Operating lease, lease term   5 years   5 years